Merck & Co., Inc. (MRK) Reports In-Line Q2 EPS of 95c; Raises Low End of FY11 Guidance Range

July 29, 2011 7:02 AM EDT
Merck & Co., Inc. (NYSE: MRK) reported Q2 EPS of $0.95, in-line with the analyst estimate of $0.95. Revenue for the quarter came in at $12.2 billion versus the consensus estimate of $11.78 million.

To cut workforce by added 12-13% by end of 2015.

Raises the lower end of its FY11 EPS range to $3.68-$3.76, the Street is currently looking for EPS of $3.74.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance